General Thoracic and Cardiovascular Surgery

, Volume 66, Issue 4, pp 201–213 | Cite as

Reconsideration of frailty in relation to surgical indication

Review Article

Abstract

Given that an increasing number of elderly patients are undergoing surgical procedures for a diversity of indications, the concept of frailty is currently being examined in more depth in clinical medicine. Established surgical risk scores designed to predict mortality are mainly focused on general demographic information and clinical factors; however, these do not account for the frailty condition. With vulnerability and low resiliency in the frail elderly, these conventional scores are unable to accurately predict postoperative outcomes including adverse complications, disability, the need for additional rehabilitation, and prolonged length of hospitalization. Over the last decade, it has been demonstrated that frailty is an independent risk factor of surgery and strongly associated with adverse postoperative outcomes and mortality. It is essential today that surgeons assimilate the concept of frailty and the relationship between frailty and surgical outcomes. A preoperative frailty assessment can assist in determining surgical indication and optimal perioperative management, ultimately impacting the postoperative functional state and quality of life. Here we review the validity of preoperative frailty assessments for surgical intervention, possible treatments for frailty, and indicate future directions in this field.

Keywords

Frailty Sarcopenia Surgery Preoperative assessment Complications 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.Google Scholar
  2. 2.
    Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901–8.Google Scholar
  3. 3.
    Chin APMJ., Dekker JM, Feskens EJ, Schouten EG, Kromhout D. How to select a frail elderly population? A comparison of three working definitions. J Clin Epidemiol. 1999;52:1015–21.Google Scholar
  4. 4.
    Gary R. Evaluation of frailty in older adults with cardiovascular disease: incorporating physical performance measures. J Cardiovasc Nurs. 2012;27:120–31.Google Scholar
  5. 5.
    Gill TM, Allore HG, Gahbauer EA, Murphy TE. Change in disability after hospitalization or restricted activity in older persons. Jama. 2010;304:1919–28.Google Scholar
  6. 6.
    Leng SX, Xue QL, Tian J, Huang Y, Yeh SH, Fried LP. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women’s Health and Aging Studies I. Exp Gerontol. 2009;44:511–6.Google Scholar
  7. 7.
    Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc. 2008;56:454–61.Google Scholar
  8. 8.
    Li H, Manwani B, Leng SX. Frailty, inflammation, and immunity. Aging Dis. 2011;2:466–73.Google Scholar
  9. 9.
    Lira FS, Rosa JC, Dos Santos RV, Venancio DP, Carnier J, Sanches PL, et al. Visceral fat decreased by long-term interdisciplinary lifestyle therapy correlated positively with interleukin-6 and tumor necrosis factor-alpha and negatively with adiponectin levels in obese adolescents. Metabolism. 2011;60:359–65.Google Scholar
  10. 10.
    Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol. 2012;2012:127362.Google Scholar
  11. 11.
    Sakuma K, Aoi W, Yamaguchi A. Current understanding of sarcopenia: possible candidates modulating muscle mass. Pflugers Arch. 2015;467:213–29.Google Scholar
  12. 12.
    Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990s-91s.Google Scholar
  13. 13.
    Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–6.Google Scholar
  14. 14.
    Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242–8.Google Scholar
  15. 15.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.Google Scholar
  16. 16.
    Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738–43.Google Scholar
  17. 17.
    Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27:17–26.Google Scholar
  18. 18.
    Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Cmaj. 2005;173:489–95.Google Scholar
  19. 19.
    Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35:526–9.Google Scholar
  20. 20.
    Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–8.Google Scholar
  21. 21.
    Schoenenberger AW, Stortecky S, Neumann S, et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J. 2013;34:684–92.Google Scholar
  22. 22.
    Jones DM, Song X, Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc. 2004;52:1929–33.Google Scholar
  23. 23.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.Google Scholar
  24. 24.
    Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, et al. Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262–6.Google Scholar
  25. 25.
    Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–36.Google Scholar
  26. 26.
    Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668–76.Google Scholar
  27. 27.
    Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc. 2008;56:2211–16.Google Scholar
  28. 28.
    Afilalo J, Mottillo S, Eisenberg MJ, Alexander KP, Noiseux N, Perrault LP, et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes. 2012;5:222–8.Google Scholar
  29. 29.
    Pamoukdjian F, Paillaud E, Zelek L, Laurent M, Levy V, Landre T, et al. Measurement of gait speed in older adults to identify complications associated with frailty: a systematic review. J Geriatr Oncol. 2015;6:484–96.Google Scholar
  30. 30.
    Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51:314–22.Google Scholar
  31. 31.
    Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. Jama. 2011;305:50–8.Google Scholar
  32. 32.
    Hardy SE, Perera S, Roumani YF, et al. Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc. 2007;55:1727–34.Google Scholar
  33. 33.
    Barry E, Galvin R, Keogh C, Horgan F, Fahey T. Is the timed up and go test a useful predictor of risk of falls in community dwelling older adults: a systematic review and meta-analysis. BMC Geriatr. 2014;14:14.Google Scholar
  34. 34.
    Savva GM, Donoghue OA, Horgan F, et al. Using timed up-and-go to identify frail members of the older population. J Gerontol A Biol Sci Med Sci. 2013;68:441–6.Google Scholar
  35. 35.
    Robinson TN, Wu DS, Sauaia A, et al. Slower walking speed forecasts increased postoperative morbidity and 1-year mortality across surgical specialties. Ann Surg. 2013;258:582–8 (discussion 88–90).Google Scholar
  36. 36.
    Ling CH, Taekema D, de Craen AJ, et al. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. Cmaj. 2010;182:429–35.Google Scholar
  37. 37.
    Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985). 2003;95:1851–60. 2003.Google Scholar
  38. 38.
    Velghe A, De Buyser S, Noens L, et al. Hand grip strength as a screening tool for frailty in older patients with haematological malignancies. Acta Clin Belg. 2016;71:227–30.Google Scholar
  39. 39.
    Rantanen T, Volpato S, Ferrucci L, et al. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51:636–41.Google Scholar
  40. 40.
    Chainani V, Shaharyar S, Dave K, et al. Objective measures of the frailty syndrome (hand grip strength and gait speed) and cardiovascular mortality: a systematic review. Int J Cardiol. 2016;215:487–93.Google Scholar
  41. 41.
    Kittiskulnam P, Chertow GM, Carrero JJ, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017.Google Scholar
  42. 42.
    Beaudart C, Zaaria M, Pasleau F, et al. Health Outcomes of Sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12:e0169548.Google Scholar
  43. 43.
    Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708–12.Google Scholar
  44. 44.
    Lee I, Ha C, Kang H. Association of sarcopenia and physical activity with femur bone mineral density in elderly women. J Exerc Nutrition Biochem. 2016;20:23–8.Google Scholar
  45. 45.
    Dirks RC, Edwards BL, Tong E, et al. Sarcopenia in emergency abdominal surgery. J Surg Res. 2017;207:13–21.Google Scholar
  46. 46.
    Dahya V, Xiao J, Prado CM, et al. Computed tomography-derived skeletal muscle index: a novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. Am Heart J. 2016;182:21–7.Google Scholar
  47. 47.
    Margadant CC, Bruns ER, Sloothaak DA, et al. Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer. Eur J Surg Oncol. 2016;42:1654–59.Google Scholar
  48. 48.
    Bokshan SL, Han AL, DePasse JM, et al. Effect of sarcopenia on postoperative morbidity and mortality after thoracolumbar spine surgery. Orthopedics. 2016;39:e1159–64.Google Scholar
  49. 49.
    Klidjian AM, Foster KJ, Kammerling RM, et al. Relation of anthropometric and dynamometric variables to serious postoperative complications. Br Med J. 1980;281:899–901.Google Scholar
  50. 50.
    Kim SW, Han HS, Jung HW, et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg. 2014;149:633–40.Google Scholar
  51. 51.
    Hewitt J, Moug SJ, Middleton M, et al. Prevalence of frailty and its association with mortality in general surgery. Am J Surg. 2015;209:254–9.Google Scholar
  52. 52.
    Dasgupta M, Rolfson DB, Stolee P, et al. Frailty is associated with postoperative complications in older adults with medical problems. Arch Gerontol Geriatr. 2009;48:78–83.Google Scholar
  53. 53.
    Robinson TN, Wallace JI, Wu DS, et al. Accumulated frailty characteristics predict postoperative discharge institutionalization in the geriatric patient. J Am Coll Surg. 2011;213:37–42 (discussion 42–4).Google Scholar
  54. 54.
    Robinson TN, Wu DS, Stiegmann GV, et al. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg. 2011;202:511–4.Google Scholar
  55. 55.
    Kristjansson SR, Nesbakken A, Jordhoy MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010;76:208–17.Google Scholar
  56. 56.
    Ronning B, Wyller TB, Jordhoy MS, et al. Frailty indicators and functional status in older patients after colorectal cancer surgery. J Geriatr Oncol. 2014;5:26–32.Google Scholar
  57. 57.
    Neuman HB, Weiss JM, Leverson G, et al. Predictors of short-term postoperative survival after elective colectomy in colon cancer patients ≥ 80 years of age. Ann Surg Oncol. 2013;20:1427–35.Google Scholar
  58. 58.
    Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011;13:439–46.Google Scholar
  59. 59.
    Farhat JS, Velanovich V, Falvo AJ, et al. Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly. J Trauma Acute Care Surg. 2012;72:1526–30 (discussion 30–1).Google Scholar
  60. 60.
    Lee DH, Buth KJ, Martin BJ, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010;121:973–8.Google Scholar
  61. 61.
    Robinson TN, Wu DS, Pointer L, et al. Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg. 2013;206:544–50.Google Scholar
  62. 62.
    Green P, Arnold SV, Cohen DJ, et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol. 2015;116:264–9.Google Scholar
  63. 63.
    Ganapathi AM, Englum BR, Hanna JM, et al. Frailty and risk in proximal aortic surgery. J Thorac Cardiovasc Surg. 2014;147:186–91.e1.Google Scholar
  64. 64.
    Pol RA, van Leeuwen BL, Visser L, et al. Standardised frailty indicator as predictor for postoperative delirium after vascular surgery: a prospective cohort study. Eur J Vasc Endovasc Surg. 2011;42:824–30.Google Scholar
  65. 65.
    Tsiouris A, Horst HM, Paone G, et al. Preoperative risk stratification for thoracic surgery using the American College of Surgeons National Surgical Quality Improvement Program data set: functional status predicts morbidity and mortality. J Surg Res. 2012;177:1–6.Google Scholar
  66. 66.
    Tsiouris A, Hammoud ZT, Velanovich V, et al. A modified frailty index to assess morbidity and mortality after lobectomy. J Surg Res. 2013;183:40–6.Google Scholar
  67. 67.
    Kistler EA, Nicholas JA, Kates SL, et al. Frailty and short-term outcomes in patients with hip fracture. Geriatr Orthop Surg Rehabil. 2015;6:209–14.Google Scholar
  68. 68.
    Krishnan M, Beck S, Havelock W, et al. Predicting outcome after hip fracture: using a frailty index to integrate comprehensive geriatric assessment results. Age Ageing. 2014;43:122–6.Google Scholar
  69. 69.
    Adams P, Ghanem T, Stachler R, et al. Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery. JAMA Otolaryngol Head Neck Surg. 2013;139:783–9.Google Scholar
  70. 70.
    Masuda T, Shirabe K, Ikegami T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.Google Scholar
  71. 71.
    Dolgin NH, Martins PN, Movahedi B, et al. Functional status predicts postoperative mortality after liver transplantation. Clin Transplant. 2016;30:1403–10.Google Scholar
  72. 72.
    McAdams-DeMarco MA, Law A, Salter ML, et al. Frailty and early hospital readmission after kidney transplantation. Am J Transplant. 2013;13:2091–5.Google Scholar
  73. 73.
    McAdams-DeMarco MA, Ying H, Olorundare I, et al. Individual frailty components and mortality. In: Kidney transplant recipients. Transplantation. 2016.Google Scholar
  74. 74.
    McAdams-DeMarco MA, King EA, Luo X, et al. Frailty, length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study. Ann Surg. 2016.Google Scholar
  75. 75.
    van Laar C, ST TI, Noyez L. Decreased physical activity is a predictor for a complicated recovery post cardiac surgery. Health Qual Life Outcomes. 2017;15:5.Google Scholar
  76. 76.
    Leung JM, Tsai TL, Sands LP. Brief report: preoperative frailty in older surgical patients is associated with early postoperative delirium. Anesth Analg. 2011;112:1199–201.Google Scholar
  77. 77.
    Joseph B, Pandit V, Zangbar B, et al. Validating trauma-specific frailty index for geriatric trauma patients: a prospective analysis. J Am Coll Surg. 2014;219:10–7.e1.Google Scholar
  78. 78.
    Joseph B, Pandit V, Zangbar B, et al. Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis. JAMA Surg. 2014;149:766–72.Google Scholar
  79. 79.
    Carey EJ, Lai JC, Wang CW, et al. A multi-center study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625–33.Google Scholar
  80. 80.
    Sinclair M, Poltavskiy E, Dodge JL, et al. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist. World J Gastroenterol. 2017;23:899–905.Google Scholar
  81. 81.
    Underwood PW, Cron DC, Terjimanian MN, et al. Sarcopenia and failure to rescue following liver transplantation. Clin Transplant. 2015;29:1076–80.Google Scholar
  82. 82.
    Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193–9.Google Scholar
  83. 83.
    McAdams-DeMarco MA, Law A, King E, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant. 2015;15:149–54.Google Scholar
  84. 84.
    Pugh J, Aggett J, Goodland A, et al. Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education. Clin Kidney J. 2016;9:324–9.Google Scholar
  85. 85.
    Bagnall NM, Faiz O, Darzi A, et al. What is the utility of preoperative frailty assessment for risk stratification in cardiac surgery? Interact Cardiovasc Thorac Surg. 2013;17:398–402.Google Scholar
  86. 86.
    Dunn MA, Josbeno DA, Tevar AD, et al. Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Am J Gastroenterol. 2016;111:1768–75.Google Scholar
  87. 87.
    Fried LP, Xue QL, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64:1049–57.Google Scholar
  88. 88.
    Xue QL, Bandeen-Roche K, Varadhan R, et al. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2008;63(9):984–90.Google Scholar
  89. 89.
    Theou O, Stathokostas L, Roland KP, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res. 2011;2011:569194.Google Scholar
  90. 90.
    Marini M, Sarchielli E, Brogi L, et al. Role of adapted physical activity to prevent the adverse effects of the sarcopenia. A pilot study. Ital J Anat Embryol. 2008;113:217–25.Google Scholar
  91. 91.
    Jones TE, Stephenson KW, King JG, et al. Sarcopenia—mechanisms and treatments. J Geriatr Phys Ther. 2009;32:83–9.Google Scholar
  92. 92.
    Chou CH, Hwang CL, Wu YT. Effect of exercise on physical function, daily living activities, and quality of life in the frail older adults: a meta-analysis. Arch Phys Med Rehabil. 2012;93:237–44.Google Scholar
  93. 93.
    Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med. 2004;34:329–48.Google Scholar
  94. 94.
    Raue U, Slivka D, Jemiolo B, et al. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci. 2007;62:1407–12.Google Scholar
  95. 95.
    Adamo ML, Farrar RP. Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev. 2006;5:310–31.Google Scholar
  96. 96.
    Nicklas BJ, Brinkley TE. Exercise training as a treatment for chronic inflammation in the elderly. Exerc Sport Sci Rev. 2009;37:165–70.Google Scholar
  97. 97.
    Marzetti E, Lawler JM, Hiona A, et al. Modulation of age-induced apoptotic signaling and cellular remodeling by exercise and calorie restriction in skeletal muscle. Free Radic Biol Med. 2008;44:160–8.Google Scholar
  98. 98.
    Psilander N, Damsgaard R, Pilegaard H. Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle. J Appl Physiol (1985). 2003;95:1038–44.Google Scholar
  99. 99.
    Vincent KR, Braith RW, Bottiglieri T, et al. Homocysteine and lipoprotein levels following resistance training in older adults. Prev Cardiol. 2003;6:197–203.Google Scholar
  100. 100.
    Borst SE, De Hoyos DV, Garzarella L, et al. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc. 2001;33:648–53.Google Scholar
  101. 101.
    Scott K, Posmontier B. Exercise interventions to reduce cancer-related fatigue and improve health-related quality of life in cancer patients. Holist Nurs Pract. 2017;31:66–79.Google Scholar
  102. 102.
    Bartali B, Frongillo EA, Bandinelli S, et al. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:589–93.Google Scholar
  103. 103.
    Milne AC, Potter J, Vivanti A, et al. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev. 2009;2:Cd003288.Google Scholar
  104. 104.
    van Wetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc. 2010;11:179–87.Google Scholar
  105. 105.
    Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012;11:278–96.Google Scholar
  106. 106.
    Tieland M, van de Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2012;13:720–6.Google Scholar
  107. 107.
    Tieland M, Dirks ML, van der Zwaluw N, et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2012;13:713–9.Google Scholar
  108. 108.
    Yamamoto K, Nagatsuma Y, Fukuda Y, et al. Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer. 2016.Google Scholar
  109. 109.
    Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.Google Scholar
  110. 110.
    Katsanos CS, Kobayashi H, Sheffield-Moore M, et al. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006;291:E381–7.Google Scholar
  111. 111.
    Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc. 2012;60:16–23.Google Scholar
  112. 112.
    Kakazu E, Kanno N, Ueno Y, et al. Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol. 2007;179:7137–46.Google Scholar
  113. 113.
    Kakazu E, Ueno Y, Kondo Y, et al. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology. 2009;50:1936–45.Google Scholar
  114. 114.
    Bassit RA, Sawada LA, Bacurau RF, et al. Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition. 2002;18:376–9.Google Scholar
  115. 115.
    Shirabe K, Yoshimatsu M, Motomura T, et al. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl. 2011;17:1073–80.Google Scholar
  116. 116.
    Okabayashi T, Iyoki M, Sugimoto T, et al. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids. 2011;40:1213–20.Google Scholar
  117. 117.
    Martone AM, Lattanzio F, Abbatecola AM, et al. Treating sarcopenia in older and oldest old. Curr Pharm Des. 2015;21:1715–22.Google Scholar
  118. 118.
    Barillaro C, Liperoti R, Martone AM, et al. The new metabolic treatments for sarcopenia. Aging Clin Exp Res. 2013;25:119–27.Google Scholar
  119. 119.
    Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748–59.Google Scholar
  120. 120.
    Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058–65.Google Scholar
  121. 121.
    Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. Jama. 2005;293:2257–64.Google Scholar
  122. 122.
    Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59:2291–300.Google Scholar
  123. 123.
    Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1:Cd007470.Google Scholar
  124. 124.
    Bauer JM, Verlaan S, Bautmans I, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2015;16:740–7.Google Scholar
  125. 125.
    Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99:4336–45.Google Scholar
  126. 126.
    Strollo F, Strollo G, More M, et al. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Aging Male. 2013;16:33–7.Google Scholar
  127. 127.
    Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2010;95:639–50.Google Scholar
  128. 128.
    Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109–22.Google Scholar
  129. 129.
    Dalla Libera L, Ravara B, Volterrani M, et al. Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol. 2004;286:C138–44.Google Scholar
  130. 130.
    Marzetti E, Groban L, Wohlgemuth SE, et al. Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats. Am J Physiol Regul Integr Comp Physiol. 2008;294:R558–67.Google Scholar
  131. 131.
    Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int. 2016;98:319–33.Google Scholar
  132. 132.
    Leger B, Derave W, De Bock K, et al. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008;11:163–75b.Google Scholar
  133. 133.
    Becker C, Lord SR, Studenski SA, et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 2015;3:948–57.Google Scholar
  134. 134.
    Latham NK, Anderson CS, Lee A, et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc. 2003;51:291–9.Google Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2017

Authors and Affiliations

  1. 1.Division of Cardiovascular SurgeryTohoku University Graduate School of MedicineSendaiJapan

Personalised recommendations